Advertisement
Notícias Forex
Verrica Pharmaceuticals Announces Agreement With Walgreens To Distribute YCANTH
Dermatology therapeutics company Verrica Pharmaceuticals Inc. (VRCA) announced Wednesday the expansion of its distribution network by entering into an agreement with Walgreen Co., a subsidiary of Walgreens Boots Alliance, Inc. (WBA), to distribute YCANTH through its specialty pharmacy.
RTTNews |
596 dias atrás
Esperion Therapeutics, Daiichi Sankyo Europe Ink $125 Mln Amendment To Their Collaboration
Esperion Therapeutics, Inc. (ESPR) and Daiichi Sankyo Europe GmbH or DSE, the European arm of Japanese pharmaceutical company Daiichi Sankyo Co., Ltd. (DSKYF.PK), announced Wednesday a $125 million amendment to their collaboration, which includes an amicable resolution to their commercial dispute and certain other adjustments to enhance the long-term value of their products.
RTTNews
|
596 dias atrás
German Unemployment Rises Less Than Expected
Germany's unemployment increased less than expected at the end of the year despite the economy undergoing a recession, official data revealed on Wednesday. Unemployment rose only 5,000 in December compared to an increase of 21,000 in November and 29,000 in October, the Federal Labor Agency reported.
RTTNews
|
596 dias atrás
Euro Hits Fresh 2-week Low Against U.S. Dollar
The euro registered losses against the U.S. dollar during the European session on Wednesday, after a data showed that German unemployment rate increased slightly at the end of the year.
RTTNews
|
596 dias atrás
UCB Announces Commercial Availability Of Zilbrysq In U.S. To Treat Generalized Myasthenia Gravis
Biopharmaceutical company UCB announced Wednesday that ZILBRYSQ (zilucoplan) is now available in the U.S. for the treatment of generalized myasthenia gravis (gMG) in adult patients who are anti-acetylcholine receptor (AChR) antibody positive.
RTTNews
|
596 dias atrás
Dyne Therapeutics Announces Positive Initial Clinical Data From ACHIEVE And DELIVER Trials
Muscle disease company Dyne Therapeutics, Inc. (DYN) announced Wednesday positive initial clinical data from its ACHIEVE trial of DYNE-101 in patients with myotonic dystrophy type 1 (DM1) and its DELIVER trial of DYNE-251 in patients with Duchenne muscular dystrophy (DMD) who are amenable to exon 51 skipping.
RTTNews
|
596 dias atrás
Sensex, Nifty Follow Global Peers Lower; Adani Group Stocks Jump After SC Verdict
Indian shares fell notably on Wednesday, even as Adani Group stocks rose sharply post the Supreme Court's dismissal of SIT investigations into allegations raised by Hindenburg Research.
RTTNews
|
596 dias atrás
more news
European Shares Subdued Ahead Of December Fed Minutes
European stocks were subdued on Wednesday as investors looked ahead to the release of Federal Reserve's December meeting minutes later in the day to gauge the rate hike trajectory. Upcoming German inflation and U.S. labor market data also remained on investors' radar.
RTTNews
|
596 dias atrás
FTSE 100 Edges Lower Ahead Of FOMC Minutes
U.K. stocks edged lower on Wednesday as investors looked ahead to the release of Federal Reserve's December meeting minutes later in the day to gauge the rate hike trajectory.
RTTNews
|
596 dias atrás
CAC 40 Slips Into Red As Investors Await FOMC Minutes
French stocks traded lower on Wednesday as Fed rate cut optimism faded and bond yields rebounded ahead of key U.S. economic data and the release of FOMC minutes that could provide further clues on the Federal Reserve's rate path.
RTTNews
|
596 dias atrás
DAX Little Changed With Labor Market Data In Focus
German stocks were little changed on Wednesday after the release of latest labour market data. Destatis reported that Germany's unemployment remained unchanged in November.
RTTNews
|
596 dias atrás
Asian Shares Decline As Yields Rise On Rate Uncertainty
Asian stocks retreated on Wednesday as an uptick in Treasury yields amid fading optimism about early rate cuts triggered a selloff in technology stocks.
RTTNews
|
596 dias atrás
Antipodean Currencies Slide Amid Risk Aversion
The Antipodean currencies such as the Australia and the New Zealand dollars weakened against their major currencies in the Asian session on Wednesday amid risk aversion, following the mostly negative cues from global markets overnight, as major currencies in the region were hit by a stronger U.S. dollar. Technology stocks are bearing the brunt after Barclays cut the iPhone maker Apple's rating to underweight and trimmed its price target.
RTTNews
|
596 dias atrás
Stay up to date!
Add Notícias to your browser
Add To Chrome
